SCHEMBL5573708

SCHEMBL5573708

C=Cc1ncc[nH]1.[Ag]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25368 0.97
SCHEMBL16924648 0.97 ALDH1A1 (0.40)
Hydrochloric Acid SCHEMBL30537233 0.95 ALDH1A1 (0.39)
Hydrochloric Acid SCHEMBL30194717 0.95 ALDH1A1 (0.39)
Hydrochloric Acid SCHEMBL28854021 0.95
Bromide SCHEMBL28631282 0.95
Hydrochloric Acid SCHEMBL10349568 0.95
Bromide SCHEMBL31686434 0.95 ALDH1A1 (0.39)
Iodide SCHEMBL28915883 0.95
SCHEMBL28759517 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1769809-A2 Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use Johnson & Johnson Vision Care, Inc. (US) 2007-04-04 EP disclosed
EP-1754494-A2 Antimicrobial lenses displaying extended efficacy, process to prepare them and methods of their use Johnson and Johnson Vision Care, Inc. (US) 2007-02-21 EP disclosed
EP-1599236-A1 ANTIMICROBIAL LENSES DISPLAYING EXTENDED EFFICACY Johnson & Johnson Vision Care, Inc. (US) 2005-11-30 EP disclosed
US-20040151755-A1 Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use JOHNSON & JOHNSON VISION CARE, INC. 2004-08-05 US disclosed
WO-2004047878-A1 ANTIMICROBIAL LENSES DISPLAYING EXTENDED EFFICACY JOHNSON & JOHNSON VISION CARE, INC. (US) 2004-06-10 WO disclosed